Impact of Hydrochlorothiazide on Nonmelanoma Skin Cancer: A Distributed Network Analysis of 11 Real-world Databases
Open Access
- 1 January 2025
- journal article
- Published by XMLink in Annals of Dermatology
- Vol. 37 (6) , 350-356
Abstract
Park YJ, et al. Ann Dermatol. 2025 Aug;37:e32. https://doi.org/10.5021/ad.25.024Keywords
Funding Information
- Ministry of Health and Welfare (HP23C0146)
This publication has 28 references indexed in Scilit:
- The association between hydrochlorothiazide use and non-melanoma skin cancer in kidney transplant recipientsClinical Kidney Journal, 2024
- Hydrochlorothiazide increases risk of nonmelanoma skin cancer in an elderly Japanese cohort with hypertension: The Shizuoka studyJAAD International, 2023
- The global epidemiology of hypertensionNature Reviews Nephrology, 2020
- Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case–control studyBritish Journal of Cancer, 2019
- Reviewing the effects of thiazide and thiazide-like diuretics as photosensitizing drugs on the risk of skin cancerJournal Of Hypertension, 2019
- Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from DenmarkJournal of the American Academy of Dermatology, 2018
- Anti-hypertensive drugs and skin cancer risk: a review of the literature and meta-analysisCritical Reviews in Oncology/Hematology, 2018
- European Code against Cancer 4th Edition: Medical exposures, including hormone therapy, and cancerCancer Epidemiology, 2015
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control groupStatistics in Medicine, 1998